Go to navigation Go to content

Media Advisory: UM System Enterprise Investment Program recipient to make exciting announcement


Christian Basi

June 25, 2013

WHAT: In February 2012 the University of Missouri System, through its Enterprise Investment Program, awarded medical device company EternoGen, LLC, up to $200,000 in seed funding. Since that initial funding, EternoGen has been able to leverage additional funds and meet major milestones that have advanced the commercialization of the company’s technology. The company plans to share these developments as well as the unique opportunities that EternoGen has in the bio-tech market.

WHEN: 10 a.m., CST, Tuesday, July 2, 2013
Opportunity for media following announcement

WHERE: MU Life Sciences Business Incubator at Monsanto Place
1601 S. Providence Rd., Columbia, Mo., 65211

Media who would like to attend the event are asked to RSVP to UM System Chief Communications Officer John Fougere no later than noon, Monday, July 1.

For St. Louis media:

WHAT: EternoGen will host a press conference in St. Louis following the Columbia event to introduce its management to the community and share its plans since receiving a $50,000 St. Louis Arch Grant.

WHEN: 3 p.m., CST, Tuesday, July 2, 2012

WHERE: Center for Emerging Technologies
4041 Forest Park Ave., St. Louis, Mo., 63108

Media who would like to attend the event are asked to RSVP to EternoGen CEO Luis Jimenez no later than 5 p.m., Monday, July 1, by emailing luis@eternogen.com.